02/26/2026
Much of the work we do at Damien Center is supported by the 340B Drug Pricing Program. The 340B program is a federal program that requires drug manufacturers to offer significant discounts on outpatient prescription drugs to certain safety-net healthcare providers (covered entities) that serve low-income and uninsured patients.
The savings we receive from 340B allow us to invest in the various support services we offer to our clients. In addition, because of 340B, 85% of Damien Center patients pay nothing for their prescriptions, while the rest pay very little.
The Indiana Family and Social Services Administration, Office of Medicaid Policy and Planning, recently announced its plan to claim 340B revenue. That means the revenue from the 340B program would go to the state, rather than to organizations like Damien Center, which serve everyone who walks through their doors, regardless of their ability to pay.
Please contact your legislators AS SOON AS POSSIBLE and ask them to amend Senate Bill 4 to protect organizations like the Damien Center.
You can easily contact your legislators using this link: https://damien.org/take-action-to-protect-340b
